Prostaglandin E1 infusion therapy in dry age-related macular degeneration

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 72, Issue 4, 2005, Pages 251-256

  Ladewig, M S ^a   Ladewig, K ^b   Guner M ^b   Heidrich, H ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

AGED; ARTICLE; AUTOFLUORESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INFUSION; MALE; PILOT STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRY EYE; FOLLOW UP; INTRALESIONAL DRUG ADMINISTRATION; READING; RETINA MACULA DEGENERATION; VISION TEST;

HUMAN ECHOVIRUS 1;

AGED; AGED, 80 AND OVER; ALPROSTADIL; DRY EYE SYNDROMES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRALESIONAL; MACULAR DEGENERATION; MALE; PILOT PROJECTS; READING; VISION TESTS;

EID: 14844292097     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2004.11.006     Document Type: Article

References (34)

1. AREDS Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 Arch. Ophthalmol. 119 2001 1417 1436
2. U. Schmidt-Erfurth, and H. Laqua Photodynamic therapy recommendations for indication and treatment Ophthalmologe 98 2001 216 219
3. H. Heidrich, J.P. Harnisch, and J. Ranft PGE1 in senile macular degeneration. A pilot study Klin. Monatsbl. Augenheilkd. 194 1989 282 284
4. J.T. Whitson Travoprost - a new prostaglandin analogue for the treatment of glaucoma Expert Opin. Pharmacother. 3 2002 965 977
5. C.M. Perry, J.K. McGavin, C.R. Culy, and T. Ibbotson Latanoprost an update of its use in glaucoma and ocular hypertension Drugs Aging 20 2003 597 630
6. H.O. Altstaedt Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1 a randomized open controlled study Prostaglandins Leukot. Essent. Fatty Acids 49 1993 573 578
7. H. Böhme, M. Brütisauer, and U. Härtet Periphere arterielle Verschlußkrankheit im Stadium III und IV. Kontrollierte Zweizentren-Studie zur Wirksamkeit von intraarteriellen Prostaglandin E1-Infusionen Med. Welt 40 1989 1501 1503
8. C. Diehm, C. Hübsch-Müller, F. Stammler, Intravenöse Prostaglandin E1 Therapie bei Patienten mit peripherer arterieller Verschlußkrankheit (pAVK) im Stadium III - eine doppelblinde, placebokontrollierte Studie, in: H. Heidrich, H. Böhme, W. Rogatti (Hrsg.), Prostaglandin E1 - Wirkung und therapeutische Wirksamkeit, Springer, Berlin, 1988, pp. 133-143.
9. H. Stiegler, C. Diehm, and E. Grom Placebokontrollierte doppelblinde Studie zur Wirksamkeit von i.v. Prostaglandin E1 bei Diabetikern mit pAVK im Stadium IV VASA 35 Suppl. 1992 164 166
10. G. Trübestein, M. Ludwig, C. Diehm, J.D. Gruss, and S. Horsch Prostaglandin E1 bei arterieller Verschlußkrankheit im Stadium III und IV - Ergebnisse einer multizentrischen Studie Dtsch. Med. Wschr. 112 1987 955 959
11. G. Trübestein, S.V. Bary, K. Breddin, C. Diehm, J.D. Gruss, H. Heinrich, S. Horsch, A. Kriessmann, U. Maass, and M. Martin Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease - a controlled randomised multicenter study VASA 28 Suppl. 1989 44 49
12. Arzneimittelkommission der deutschen Ärzteschaft, Empfehlungen zur Therapie der peripheren arteriellen Verschlußkrankheit, Auflage, 2003, p. 2.
13. H. Heidrich, K. Breddin, G. Rudofsky, and P. Scheffler Cardiopulmonary effects and safety of prostaglandin E1 a review Int. J. Angiol. 3 1994 160 168
14. F.L. Ferris, A. Kassoff, G.H. Bresnick, and I. Bailey New visual acuity charts for clinical research Am. J. Ophthalmol. 1994 91 96
15. M.F. Marmor, D.C. Hood, D. Keating, M. Kondo, M.W. Seeliger, and Y. Miyake Guidelines for basic multifocal electroretinography (mfERG) Doc. Ophthalmol. 106 2003 105 115
16. R. Klein, and B.E. Klein Ten-year incidence and progression of age-related maculopathy the Beaver dam eye study Ophthalmology 109 2002 1767 1779
17. K. Scilly, G.R. Jackson, A.V. Cdeciyan, M.G. Maureen, S.G. Jacobson, and C. Owsley Early age-related maculopathy and selfreported visual difficulty in daily life Ophthalmology 109 2002 1235 1242
18. F.G. Holz, M. Gross-Jendroska, A. Eckstein, C.R. Hogg, G.B. Arden, and A.C. Bird Colour contrast sensitivity in patients with age-related Bruch's membrane changes Ger. J. Ophthalmol. 4 1995 336 341
19. F.G. Holz, C. Bellman, S. Staudt, F. Schutt, and H.E. Volcker Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration Invest. Ophthalmol. Vis. Sci. 27 2001 1051 1056
20. E.E. Sutter, and D. Tran The field topography of ERG components in man - I. The photopic luminance response Vision Res. 32 1992 433 446
21. M.W. Seeliger, B. Jurklies, U. Kellner, A. Palmowski, M. Bach, and U. Kretschmann Multifokale Elektroretinographie (mfERG) Ophthalmologe 98 2001 1112 1127
22. 1) in peripheral arterial occlusive disease (PAD) VASA 33 2004 119 124
23. A.V. Ershov, and N.G. Bazan Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells J. Neurosci. Res. 60 2000 328 337
24. T.K. Garg, and J.Y. Chang Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2 BMC Ophthalmol. 3 2003 5
25. M.A. Melrose, L.E. Magargal, R.E. Goldberg, and W.H. Annesley Jr Subretinal neovascular membranes associated with choroidal nonperfusion and retinal ischemia Ann. Ophthalmol. 19 1987 396 399
26. D. Pauleikhoff, J.C. Chen, I.H. Chisholm, and A.C. Bird Choroidal perfusion abnormality with age-related Bruch's membrane change Am. J. Ophthalmol. 109 1990 211 217
27. F.G. Holz, T.J. Wolfensberger, B. Piguet, M. Gross-Jendroska, J.A. Wells, D.C. Minassian, I.H. Chisholm, and A.C. Bird Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors Ophthalmology 101 1994 1522 1528
28. A. Scheider, and L. Neuhauser Fluorescence characteristics of drusen during indocyanine-green angiography and their possible correlation with choroidal perfusion Ger. J. Ophthalmol. 1 1992 328 334
29. J. Olver, D. Pauleikhoff, and A.C. Bird Morphometric analysis of age changes in the chorioicapillaris Invest. Ophthalmol. Vis. Sci. 31 Suppl. 1990 47
30. R.S. Ramratten, T.L. von der Schaft, C.M. Mooy, W.C. de Bruijn, P.G. Mulder, and P.T. de Jong Morphometric analysis of Bruch's membrane, the choriocapillaris and the choroid in aging Invest. Ophthalmol. Vis. Sci. 35 1994 2857 2864
31. J.D. Gass Pathogenesis of disciform detachment of the neuroepithelium Am. J. Ophthalmol. 63 Suppl. 1967 1 139
32. E. Friedman The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration Am. J. Ophthalmol. 130 2000 658 663
33. A.L. Kornzweig, Changes in the choriocapillaris associated with senile macular degeneration, Ann. Ophthalmol. 9 (1977) 753-756, 759-762.
34. J.R. Vingerling, I. Dielemans, M.L. Bots, A. Hofman, D.e. Grobbe, and P.T. de Jong Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study Am. J. Epidemiol. 142 1995 404 409